The World Anti-Doping Agency (WADA) was established in 1999 as an international independent agency composed and funded equally by the sport movement and governments of the world.

Its key activities include scientific research, education, development of anti-doping capacities, and monitoring of the World Anti Doping Code (Code) – the document harmonizing anti-doping policies in all sports and all countries.

*IMPORTANT INFORMATION RE BETA BLOCKERS*

Circular
 – Drug Testing in Darts Update on Beta Blockers

• 1 – Below is the official announcement by the DRA on Beta Blockers
• 2 – The DRA Rule 7.1.2 (ii)
• 3 – User friendly terms of what this means for members

1- Since 6th January 2019 unapproved use of Beta-Blockers has been subject to disciplinary rules (as then amended).

Given the complexity of processing Therapeutic Use Exemption Applications and other technical procedures required which flow from these rule changes, the DRA has been in detailed communication with UK Anti-Doping (UKAD) to implement these changes. Unfortunately, we have been unable to finalise our procedures with UKAD and this has proved more difficult than originally anticipated. Accordingly, and so that testing can continue the DRA Board of Directors has made the following decision:

The application of section 7.1.2 (ii) of the DRA Rules is suspended until further notice. Please note that this suspension does not affect your obligation to inform the DRA if you are currently prescribed Beta-Blockers. It also does not affect your obligations in respect of other medications and TUEs.

We remind all players that it is your responsibility to have any medication you use checked to see if it or any of its ingredients are prohibited. If any player is unsure or has any questions regarding any medications (including Beta-Blockers), please contact us using the email addresses or a telephone number below.

You can also check your medication on the Global DRO website: CLICK HERE

If you need any further assistance or help, please contact us using the following email addresses: timo@moore-tibbits.co.uk and monikak@moore-tibbits.co.uk Alternatively, you can speak to Tim Ollerenshaw or Monika Krtenova using this following telephone number +44(0)1926 674544 – Dated 3rd June 2019

2 – DRA Rule 7.1.2 (ii)

(ii) the unauthorised use by a Player of Beta-Blockers [in or out of competition] for incidents occurring on or after 6th January 20191;

3 – What does this mean

NOTE a
Players will still need to check all Medications and will still need a TUE Certificate for all prohibited substances/medications.

NOTE b
If a player is on Beta Blockers, they are obliged to inform the DRA but can use this medication with a TUE form, We do not recommend their using Beta-Blockers, if there is an alternative medication available, but it will not be treated as a Disciplinary matter currently, if they are tested and found to have Beta-Blockers in their system.

They do not need a TUE Form for Beta-Blockers now as there is currently no procedure in place to deal with Beta-Blockers TUE Forms (this will obviously change once such a procedure has been adopted). At the moment, their only obligation in respect of Beta-Blockers is to inform the DRA.

If you have any issues, comments or queries please refer to the above correspondence or contact your PDPA

OUR VISION

A world where all athletes can compete in a doping-free sporting environment.

OUR CORE VALUES

INTEGRITY

• We are the guardian of the values and spirit inherent in the Code.
• We are impartial, objective, balanced and transparent.
• We observe the highest ethical standards and avoid improper influences or conflicts of interests that would undermine our independent and unbiased judgment.
• We develop policies, procedures and practices that reflect justice, equity and integrity.

ACCOUNTABILITY

• We govern and manage in accordance with the values and spirit of the Code.
• We are accountable to our funding bodies, while maintaining appropriate independence from undue influence.
• We respect the rights and integrity of clean athletes.

EXCELLENCE

• We conduct business professionally.
• We develop innovative and practical solutions to assist with stakeholder Code implementation and compliance.
• We benchmark off and apply best practice standards to all our activities.

THE AGENCY’S HISTORY

After the events that shook the world of cycling in the summer of 1998, the International Olympic Committee (IOC) decided to convene a World Conference on Doping, bringing together all parties involved in the fight against doping.

The First World Conference on Doping in Sport held, in Lausanne, Switzerland, on February 2-4, 1999, produced the Lausanne Declaration on Doping in Sport. This document provided for the creation of an independent international anti-doping agency to be operational for the Games of the XXVII Olympiad in Sydney in 2000.

Pursuant to the terms of the Lausanne Declaration, the World Anti-Doping Agency (WADA) was established on November 10, 1999, in Lausanne to promote and coordinate the fight against doping in sport internationally.

WADA was set up as a foundation under the initiative of the IOC with the support and participation of intergovernmental organizations, governments, public authorities, and other public and private bodies fighting doping in sport. The Agency consists of equal representatives from the Olympic Movement and public authorities.

The Prohibited List is a cornerstone of the World Anti-Doping Code and a key component of harmonisation. The List is updated annually following an extensive consultation process facilitated by WADA.

The 2018 List is valid from January 1 to December 31, 2018.

• WADA Website CLICK HERE
• Prohibited at all times list CLICK HERE
• Prohibited in competition CLICK HERE
• Prohibited in particular sports CLICK HERE
• Prohibited Substances – Go to the Global DRO area on this website and add your substance to be checked. CLICK HERE

What Is The Prohibited List?
The Prohibited List (List) was first published in 1963 under the leadership of the International Olympic Committee. Since 2004, as mandated by the World Anti-Doping Code (Code), WADA is responsible for the preparation and publication of the List.

The List is a cornerstone of the Code and a key component of harmonisation. It is an International Standard identifying substances and methods prohibited in-competition, out-of-competition and in particular sports.

Substances and methods are classified by categories (e.g., steroids, stimulants, gene doping).
The use of any prohibited substance by an athlete for medical reasons is possible by virtue of a Therapeutic Use Exemption (TUE)

How Is The List Updated?
Guidelines for the annual review and consequent publication of the List are outlined in the Code. WADA’s role is one of facilitator of the consultation process.

The agreed process for the annual consideration of the List includes three meetings (see timeline below) of WADA’s List Expert Group with a draft discussion List being published and circulated for consultation in June, following the second meeting.

At its third meeting in September, the List Expert Group, following consideration of the submissions received from the consultation process, recommends the new List to the Health, Medical and Research Committee which in turn makes recommendations to WADA’s Executive Committee.

The Executive Committee finalizes the List at its September meeting.
The updated List is published by October 1 and comes into effect on January 1 the following year.